SecBot SecBot
Insider Cluster (2 insiders) ·Filed Sep 11, 2026

UTHR

UNITED THERAPEUTICS Corp
NEUTRAL
Impact 3/10
Horizonweeks Processed2mo ago
Insider cluster: 2 insiders, $1.6M total
Actionable Insight • Neutral

The CEO's sales are mechanically tied to option exercises and represent a tiny fraction of market cap. The $477.6M ASR is the more material event, it signals management's view that shares are undervalued and will mechanically reduce share count by ~1.5M shares (assuming ~$320 avg buyback price). Monitor Q4 2026 final settlement for actual share retirement. No bearish read-through from insider sales.

DirectionNeutral
Confidencehigh
Horizonweeks

How the stock moved after the report

NEUTRAL VIEWSTOCK ABOVE ENTRY AT T+20
Entry
$502.70
T+0 close · Sep 11, 2026 · via day close
Latest settled
+9.43%
T+20 · $550.10 · next T+60 in 21d
Vs SPY
+7.17%
α at T+20
Latest observation
+18.74%
T+43 · FF3 residual α
  1. T+0 · Sep 14 $502.70entry
  2. T+1 · 2mo ago −0.47%α −0.01% · $500.35
  3. T+5 · 8w ago −1.91%α −3.57% · $493.10
  4. T+20 · 5w ago +9.43%α +7.17% · $550.10
  5. T+45 · todayOpen
  6. T+60 · in 21d Pending
Loading chart...

How similar events traded

How similar events traded

See how far stocks moved after events like this one.

Subscribe for Full Access

Executive Summary

CEO Martine Rothblatt sold ~$6.9M in open-market shares on Sep 9-10, 2026, while simultaneously exercising stock options. General Counsel Paul Mahon sold $740K on Sep 3. The cluster follows a $477.6M accelerated share repurchase agreement announced Sep 8. Total open-market sales of ~$7.6M represent ~0.04% of UTHR's $21.3B market cap, trivial in proportion. The sales appear liquidity-driven (option exercise cash-out) rather than a bearish signal, consistent with the weak predictive power of insider sales clusters per academic literature.

Key Financial Metrics

Direction
selling
Total Value
$7.6M
Insiders
2

Key Facts

  • CEO Martine Rothblatt sold 12,917 open-market shares totaling ~$6.9M on Sep 9-10, 2026
  • CEO simultaneously exercised 28,500 stock options (19,000 at $117.76, 9,500 at $0)
  • General Counsel Paul Mahon sold 1,500 shares for $740K on Sep 3, 2026
  • Company announced $477.6M accelerated share repurchase agreement with Citi on Sep 8, 2026
  • Total open-market sales of ~$7.6M represent ~0.04% of $21.3B market cap

Financial Impact

Total insider open-market sales of ~$7.6M vs $21.3B market cap (0.04%), immaterial

dilutioninsider ownership

Risk Factors

  • CEO sold ~$6.9M even after a $477.6M buyback announcement, could signal personal diversification needs or a muted view on near-term upside
  • ASR exposes company to mark-to-market risk if stock rises during the averaging period, potentially reducing share count less than expected

Market Snapshot

Exchange
Nasdaq
Sector
Pharmaceutical Preparations
Analyst Consensus
82% bullish (22 analysts)

Investment Themes

Documents Analyzed

This report is based on 1 SEC document filed with EDGAR.

DocumentAccession Number
CLUSTER Data (Synthetic)cluster-UTHR-1789192954962

Track record

123 reports on UTHR

Performance horizon

4 of 9 bullish or bearish reports moved the stock their way by T+5. Best: +10.30% at T+20 after the Oct 14, 2026 report. 5 of 9 went positive at some point.

Filters
  1. Nov 16, 2026today Insider Cluster Neutral 3/10 Entry price pending
  2. Nov 13, 20263d ago Insider Cluster Bearish 4/10 Entry $597.50 Now $587.88 +1.61% settles Nov 23
  3. Nov 12, 20264d ago Insider Cluster Neutral 2/10 Entry $591.17 Now $587.88 −0.56% settles Nov 20
  4. Nov 10, 20266d ago Insider Cluster Neutral 2/10 Entry $595.66 Now $587.88 −1.31% settles Nov 18
  5. Nov 9, 20267d ago Insider Cluster Neutral 2/10 Entry $588.61 Now $587.88 −0.12% settles Nov 17
  6. Nov 9, 20267d ago 144 Neutral 2/10 Entry $588.61 Now $587.88 −0.12% settles Nov 17
  7. Nov 6, 202610d ago Insider Cluster Neutral 2/10 Entry $582.46 to $587.88 Now $587.88 +0.93% ▲ +0.93% +2.62% vs SPY
  8. Nov 5, 202611d ago Insider Cluster Neutral 2/10 Entry $562.02 to $591.17 Now $587.88 +4.60% ▲ +5.19% +2.59% vs SPY
  9. Nov 5, 202611d ago 144 Neutral 2/10 Entry $562.02 to $591.17 Now $587.88 +4.60% ▲ +5.19% +2.59% vs SPY
  10. Nov 4, 202612d ago SC 13G/A Neutral 2/10 Entry $565.72 to $593.31 Now $587.88 +3.92% ▲ +4.88% +1.59% vs SPY
Showing 10 of 123

US Market Status

Market Closed · Opens Wed (10h 48m)

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Sep 12, 2026